Author:
Weyne Jonathan,Blauvelt Andrew,de Bruin-Weller Marjolein,Prens Errol,Asbell Penny,Sierka Debra,Chen Zhen,Shumel Brad
Funder
Sanofi
Regeneron Pharmaceuticals
Publisher
Springer Science and Business Media LLC
Reference18 articles.
1. Thyssen JP, Toft PB, Halling-Overgaard A-S, Gislason GH, Skov L, Egeberg A. Incidence, prevalence, and risk of selected ocular disease in adults with atopic dermatitis. J Am Acad Dermatol. 2017;77:280–6.
2. US Department of Health and Human Services Public Health Service, National Center for Health Statistics. Eye conditions and related need for medical care among persons 1–74 years of age: United States, 1971–72. DHHS Publication No. (PHS) 83–1678. 1983. https://www.cdc.gov/nchs/data/series/sr_11/sr11_228.pdf. Accessed 11 Feb 2020.
3. Beck KM, Seitzman GD, Yang EJ, Sanchez IM, Liao W. Ocular co-morbidities of atopic dermatitis. Part 1: associated ocular diseases. Am J Clin Dermatol. 2019;20:797–805.
4. Chen JJ, Applebaum DS, Sun GS, Pflugfelder SC. Atopic keratoconjunctivitis: a review. J Am Acad Dermatol. 2014;70:569–75.
5. Garrity JA, Liesegang TJ. Ocular complications of atopic dermatitis. Can J Ophthalmol. 1984;19:21–4.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献